Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Applied Dna Scns (NQ: APDN ) 4.370 -0.630 (-12.60%) Streaming Delayed Price Updated: 3:59 PM EDT, Apr 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 84,077 Open 4.810 Bid (Size) 4.170 (1) Ask (Size) 4.550 (1) Prev. Close 5.000 Today's Range 4.100 - 4.920 52wk Range 0.2200 - 5.070 Shares Outstanding 16,978,703 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program April 25, 2024 Via ACCESSWIRE Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 24, 2024 Via Benzinga Performance YTD +604.73% +604.73% 1 Month +921.03% +921.03% 3 Month +602.57% +602.57% 6 Month +426.82% +426.82% 1 Year +337.04% +337.04% More News Read More Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday April 24, 2024 Via InvestorPlace Recap: Applied DNA Sciences Q1 Earnings February 08, 2024 Via Benzinga Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results February 08, 2024 Via ACCESSWIRE Applied DNA Announces 1-For-20 Reverse Stock Split April 22, 2024 Via ACCESSWIRE The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover April 09, 2024 Via MarketBeat Topics Cannabis Exposures Cannabis 12 Health Care Stocks Moving In Wednesday's After-Market Session March 20, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session March 18, 2024 Via Benzinga Earnings Scheduled For February 8, 2024 February 08, 2024 Via Benzinga Earnings Preview For Applied DNA Sciences February 07, 2024 Via Benzinga Applied DNA Sciences: Q4 Earnings Insights December 07, 2023 Via Benzinga Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results December 07, 2023 Via ACCESSWIRE Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start March 18, 2024 Via ACCESSWIRE Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress March 14, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Monday's After-Market Session February 05, 2024 Via Benzinga Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024 February 05, 2024 Via ACCESSWIRE Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules February 02, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 31, 2024 Via Benzinga Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules January 31, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Monday's Pre-Market Session December 18, 2023 Via Benzinga Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow December 14, 2023 Via ACCESSWIRE Lululemon To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday December 08, 2023 Via Benzinga APDN Stock Earnings: Applied DNA Sciences Beats EPS, Misses Revenue for Q4 2023 December 07, 2023 Via InvestorPlace Earnings Scheduled For December 7, 2023 December 07, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.